CAS 133052-90-1|Bisindolylmaleimide I (GF109203X)
| Common Name | Bisindolylmaleimide I (GF109203X) | ||
|---|---|---|---|
| CAS Number | 133052-90-1 | Molecular Weight | 412.484 |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 685.6±55.0 °C at 760 mmHg |
| Molecular Formula | C25H24N4O2 | Melting Point | 208-210ºC |
| MSDS | USA | Flash Point | 368.5±31.5 °C |
| Symbol | GHS07, GHS08 | Signal Word | Warning |
Names
| Name | 3-[1-[3-(dimethylamino)propyl]indol-3-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione |
|---|---|
| Synonym | More Synonyms |
Bisindolylmaleimide I (GF109203X) BiologicalActivity
| Description | Bisindolylmaleimide I (GF109203X) is a highly selective, cell-permeable, and reversible protein kinase C (PKC) inhibitor with a Ki of 14 nM. |
|---|---|
| Related Catalog | Signaling Pathways >>Epigenetics >>PKCSignaling Pathways >>TGF-beta/Smad >>PKCResearch Areas >>Metabolic Disease |
| Target | Bovine brain PKC:10 nM (IC50) PKCβII:16 nM (IC50) PKCβI:17 nM (IC50) PKCα:20 nM (IC50) PKCγ:20 nM (IC50) FDGFR:65 μM (IC50) |
| In Vitro | Bisindolylmaleimide I is a competitive inhibitor with respect to ATP (Ki=14 nM) and displays high selectivity for PKC as compared to five different protein kinases. GF 109203X efficiently prevents PKC-mediated phosphorylations of an Mr=47,000 protein in platelets and of an Mr=80,000 protein in Swiss 3T3 cells. GF 109203X inhibits collagen- and a-thrombin-induced platelet aggregation as well as collagen-triggered ATP secretion. However, ADP-dependent reversible aggregation is not modified. In Swiss 3T3 fibroblasts, GF 109203X reverses the inhibition of epidermal growth factor binding induced by phorbol 12,13-dibutyrate and prevents [3H] thymidine incorporation into DNA, only when this is elicited by growth promoting agents which activate PKC[1]. |
| In Vivo | Pial arteriole diameter changes are monitored using a closed cranial window in vivo microscopy technique. The pial arteriole dilatory response associated with SNS is decreased by 45%, when comparing DM vs either ND or TR rats. Also, pial arteriolar dilations to topical KCl and NS1619 are largely attenuated in DM rats, but not in ND or TR animals. These responses are completely restored by the acute application of Bisindolylmaleimide I to the brain surface. The PKC inhibitor has no effect on vascular responses in normoglycemic and TR animals. In conclusion, DM-associated chronic impairment of neurovascular coupling may be readily reversed by a PKC-α/β/γ inhibitor or prevented via pancreatic islet transplantation. Specific PCK isoforms (α/β/γ) are believed to be mechanistically linked to the neurovascular uncoupling seen with hyperglycemia[2]. |
| Kinase Assay | Assay of PKC is arrayed by measuring 32Pi transferred from [γ-32Pi] ATP to lysine-rich histone type Ill-s. The reaction mixture (80 μL) contains 50 mM Tris-HCI, pH 7.4. 100 μM CaCl2, 10 mM MgCI2, 37.5 μg/mL histone type Ill-s, l0 μM [γ-32Pi] ATP (1250cpm/pmol), 31 μM bovine brain phosphatidylserine and 0.5 μM 1,2 sn-dioleylglycerol. 15 μL of purified PKC (final concentration in assay 0.38 μg/mL) is added to the incubation mixture. After 10 minutes, the reaction is stopped by addition of at 30 μL of casein 30 mg/mL and 0.9 mL of 12% trichlomacetic acid[1]. |
| Animal Admin | Three sets of Lewis rats is used for this study: 1) euglycemic 4–6 month old non-diabetic controls (ND group, n=11); 2) streptozotocin (STZ)-treated diabetic rats (6 month old, 4 months post-STZ) (DM group, n=6); and 3) STZ-treated diabetic animals, subjected to pancreatic islet transplantation soon after the establishment of the diabetic model, studied 100–110 days after the transplant (TR group, n=7)[2]. |
| References | [1]. Toullec D, et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991 Aug 25;266(24):15771-81. [2]. Vetri F, et al. Impairment of neurovascular coupling in Type 1 Diabetes Mellitus in rats is prevented by pancreatic islet transplantation and reversed by a semi-selective PKC inhibitor. Brain Res. 2017 Jan 15;1655:48-54. |
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 685.6±55.0 °C at 760 mmHg |
| Melting Point | 208-210ºC |
| Molecular Formula | C25H24N4O2 |
| Molecular Weight | 412.484 |
| Flash Point | 368.5±31.5 °C |
| Exact Mass | 412.189911 |
| PSA | 70.13000 |
| LogP | 3.88 |
| Vapour Pressure | 0.0±2.1 mmHg at 25°C |
| Index of Refraction | 1.687 |
| InChIKey | QMGUOJYZJKLOLH-UHFFFAOYSA-N |
| SMILES | CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21 |
| Storage condition | 2-8°C |
| Water Solubility | DMSO: ~1 mg/mlsoluble | Insoluble in water. |
Safety Information
| Symbol | GHS07, GHS08 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H351 |
| Precautionary Statements | P281 |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R40 |
| Safety Phrases | 36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | UX9590000 |
Articles79
More Articles| Tumour suppressor TRIM33 targets nuclear β-catenin degradation. Nat. Commun. 6 , 6156, (2015) Aberrant activation of β-catenin in the nucleus has been implicated in a variety of human cancers, but the fate of nuclear β-catenin is unknown. Here we demonstrate that the tripartite motif-containin... | |
| Role of SM22 in the differential regulation of phasic vs. tonic smooth muscle. Am. J. Physiol. Gastrointest. Liver Physiol. 308(7) , G605-12, (2015) Preliminary proteomics studies between tonic vs. phasic smooth muscles identified three distinct protein spots identified to be those of transgelin (SM22). The latter was found to be distinctly downre... | |
| Excitation of rat sympathetic neurons via M1 muscarinic receptors independently of Kv7 channels. Pflugers Arch. 466(12) , 2289-303, (2014) The slow cholinergic transmission in autonomic ganglia is known to be mediated by an inhibition of Kv7 channels via M1 muscarinic acetylcholine receptors. However, in the present experiments using pri... |
Synonyms
| MFCD00236428 |
| bisindolylmaleimide i |
| 1H-Pyrrole-2,5-dione, 3-[1-[3-(dimethylamino)propyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)- |
| RBT205 INHIBITOR |
| 3-[1-[3-(dimethylamino)propyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrolyl-2,5-dione |
| 3-{1-[3-(Dimethylamino)propyl]-1H-indol-3-yl}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione |
| BIM-1 |
| GF 109203X |
